Processa Pharmaceuticals, Inc. (PCSA) has a market capitalization of $6.5M and trades at $2.87. The 52-week range is 1.76-19.625.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.3, Earnings Per Share (EPS) of $-10.36.
The stock has a beta of 0.89, operates in the Healthcare sector.
